Keyphrases
Pancreatic Cancer
81%
Tumor
70%
CCR2
68%
Resection
63%
Pancreatic Ductal Adenocarcinoma
57%
Tumor-associated Macrophages
48%
Recurrence-free Survival
43%
Macrophages
36%
Overall Survival
35%
Targeted Tumor
35%
Monocytes
35%
Pancreatic Neuroendocrine Tumors (pNETs)
34%
Acute Cholecystitis
34%
Inflammation
25%
Tumor Subtype
22%
National Surgical Quality Improvement Program (NSQIP)
22%
Liver Metastasis
22%
Inflammatory Monocytes
21%
Human Pancreatic Cancer
21%
Chemokine (C-C motif) Ligand 2 (CCL2)
20%
Immunosuppressive Myeloid Cells
20%
Resectable Pancreatic Cancer
20%
Histologic
19%
Adjuvant Therapy
19%
Survival Benefit
19%
Breast Cancer
19%
Chemotherapy Response
19%
Liver Transplantation
18%
FOLFIRINOX
18%
Poor Prognosis
18%
Cell Response
18%
Minimally Invasive Pancreaticoduodenectomy
17%
Social Belonging
17%
Incidental
17%
Surgical Residents
17%
Novel Treatments
17%
Aortic Aneurysm
17%
Aortic Root Aneurysm
17%
Agonism
17%
Anticancer Immune Response
17%
Patient Response
17%
Conventional Therapy
17%
Resident Well-being
17%
Single Sample
17%
Robotic Liver
17%
Comparative Effectiveness
17%
Stemness
17%
Retrospective Cohort
17%
Chromogranin A
17%
Tumor-infiltrating Macrophages
17%
Medicine and Dentistry
Neoplasm
100%
Surgery
90%
Recurrence Free Survival
42%
Macrophage
38%
Overall Survival
37%
Pancreaticoduodenectomy
34%
Pancreas Islet Cell Tumor
34%
Acute Cholecystitis
34%
Pancreas Adenocarcinoma
34%
Recurrent Disease
34%
Pancreas Cancer
34%
Neutrophil
34%
Liver Metastasis
28%
Hepatectomy
27%
Diseases
23%
Colorectal Carcinoma
22%
Cholecystectomy
21%
Observational Study
21%
Liver Graft
20%
Lymphocyte
19%
Chemotherapy
19%
Adjuvant Therapy
19%
Liver Transplantation
17%
Surgical Approach
17%
Surgical Oncology
17%
Aortic Root
17%
Persistent Truncus Arteriosus
17%
Incidental Finding
17%
Pancreas Fistula
17%
Intervention in Congenital Heart Disease
17%
Rectum Cancer
17%
Health Care Cost
17%
Aneurysm
17%
Aortic Aneurysm
17%
Perivascular Epithelioid Cell Tumour
17%
Cholecystitis
17%
Bowel Resection
17%
Metabolic Syndrome
17%
Metastatic Colorectal Cancer
17%
Cancer Stem Cell
17%
Clinical Stage
17%
Surgical Risk
17%
Small Intestine Resection
17%
Esophagectomy
17%
Esophageal Cancer
17%
Myeloid-Derived Suppressor Cell
17%
Chromogranin A
17%
Gastroenteropancreatic Neuroendocrine Tumor
17%
Chemoradiotherapy
17%
Minimally Invasive Procedure
17%